149 related articles for article (PubMed ID: 28739755)
1. Nomogram Model of LNR Predicts Survival in Premenopausal Patients with Node-positive Luminal Breast Cancer.
Qin T; Zeng YD; Lu Q; Zhang X; Qin GE; Zheng Q; Xu F; Peng R; Yuan Z; Wang S
Anticancer Res; 2017 Aug; 37(8):4575-4586. PubMed ID: 28739755
[TBL] [Abstract][Full Text] [Related]
2. The lymph node ratio as an independent prognostic factor for non-metastatic node-positive breast cancer recurrence and mortality.
Solak M; Turkoz FP; Keskin O; Aksoy S; Babacan T; Sarici F; Kertmen N; Sever AR; Altundag K
J BUON; 2015; 20(3):737-45. PubMed ID: 26214625
[TBL] [Abstract][Full Text] [Related]
3. Lymph node ratio and pN staging in patients with node-positive breast cancer: a report from the Korean breast cancer society.
Ahn SH; Kim HJ; Lee JW; Gong GY; Noh DY; Yang JH; Jung SS; Park HY
Breast Cancer Res Treat; 2011 Nov; 130(2):507-15. PubMed ID: 21858659
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of lymph node ratio in node-positive breast cancer: a Dutch nationwide population-based study.
Dings PJ; Elferink MA; Strobbe LJ; de Wilt JH
Ann Surg Oncol; 2013 Aug; 20(8):2607-14. PubMed ID: 23536053
[TBL] [Abstract][Full Text] [Related]
5. Metastatic axillary lymph node ratio (LNR) is prognostically superior to pN staging in patients with breast cancer--results for 804 Chinese patients from a single institution.
Xiao XS; Tang HL; Xie XH; Li LS; Kong YN; Wu MQ; Yang L; Gao J; Wei WD; Xie X
Asian Pac J Cancer Prev; 2013; 14(9):5219-23. PubMed ID: 24175804
[TBL] [Abstract][Full Text] [Related]
6. [Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].
Li Y; Sun BS; Zhang ZF; Zhang LM; Wang CL
Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1682-6. PubMed ID: 21914316
[TBL] [Abstract][Full Text] [Related]
7. Lymph Node Ratio in Sentinel Lymph Node Biopsy Era: Are We Losing Prognostic Information?
Quintyne KI; Woulfe B; Coffey JC; Merrigan A; Gupta RK
Clin Breast Cancer; 2017 Apr; 17(2):117-126. PubMed ID: 27592541
[TBL] [Abstract][Full Text] [Related]
8. Micrometastatic node-positive breast cancer: long-term outcomes and identification of high-risk subsets in a large population-based series.
Truong PT; Lesperance M; Li KH; MacFarlane R; Speers CH; Chia S
Ann Surg Oncol; 2010 Aug; 17(8):2138-46. PubMed ID: 20151215
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of residual nodal burden using lymph node ratio in locally advanced breast cancer after neoadjuvant chemotherapy.
Agarwal R; Philip A; Pavithran K; Rajanbabu A; Goel G; Vijaykumar DK
Indian J Cancer; 2019; 56(3):228-235. PubMed ID: 31389386
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a nomogram for predicting survival on the base of modified lymph node ratio in breast cancer patients.
Wen J; Yang Y; Liu P; Ye F; Tang H; Huang X; Zhong S; Xie X
Breast; 2017 Jun; 33():14-22. PubMed ID: 28259045
[TBL] [Abstract][Full Text] [Related]
11. Nomograms predict survival of patients with lymph node-positive, luminal a breast cancer.
Li Y; Ma L
BMC Cancer; 2021 Aug; 21(1):965. PubMed ID: 34454451
[TBL] [Abstract][Full Text] [Related]
12. Using the lymph nodal ratio to predict the risk of locoregional recurrence in lymph node-positive breast cancer patients treated with mastectomy without radiation therapy.
Wu SG; Chen Y; Sun JY; Li FY; Lin Q; Lin HX; He ZY
Radiat Oncol; 2013 May; 8():119. PubMed ID: 23672513
[TBL] [Abstract][Full Text] [Related]
13. Lymph node ratio should be considered for incorporation into staging for breast cancer.
Chagpar AB; Camp RL; Rimm DL
Ann Surg Oncol; 2011 Oct; 18(11):3143-8. PubMed ID: 21847696
[TBL] [Abstract][Full Text] [Related]
14. Lymph node ratio and pN staging show different superiority as prognostic predictors depending on the number of lymph nodes dissected in Chinese patients with luminal A breast cancer.
Wang F; He W; Qiu H; Wang X; Guo G; Chen X; Rong Y; Zhou F; Yin C; Yuan Z; Xia L
Clin Breast Cancer; 2012 Dec; 12(6):404-11. PubMed ID: 23026023
[TBL] [Abstract][Full Text] [Related]
15. Additional prognostic value of lymph node ratio over pN staging in different breast cancer subtypes based on the results of 1,656 patients.
Ataseven B; Kümmel S; Weikel W; Heitz F; Holtschmidt J; Lorenz-Salehi F; Kümmel A; Traut A; Blohmer J; Harter P; du Bois A
Arch Gynecol Obstet; 2015 May; 291(5):1153-66. PubMed ID: 25367604
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of lymph node ratio in node-positive breast cancer in Egyptian patients.
Elkhodary TR; Ebrahim MA; Hatata EE; Niazy NA
J Egypt Natl Canc Inst; 2014 Mar; 26(1):31-5. PubMed ID: 24565680
[TBL] [Abstract][Full Text] [Related]
17. The lymph node ratio as an independent prognostic factor for node-positive triple-negative breast cancer.
He M; Zhang JX; Jiang YZ; Chen YL; Yang HY; Tang LC; Shao ZM; Di GH
Oncotarget; 2017 Jul; 8(27):44870-44880. PubMed ID: 28496004
[TBL] [Abstract][Full Text] [Related]
18. Lymph node ratio: a proposed refinement of current axillary staging in breast cancer patients.
Schiffman SC; McMasters KM; Scoggins CR; Martin RC; Chagpar AB
J Am Coll Surg; 2011 Jul; 213(1):45-52; discussion 52-3. PubMed ID: 21601490
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of lymph node ratio in poor prognosis node-positive breast cancer patients in Saudi Arabia.
Ibrahim EM; Elkhodary TR; Zekri JM; Bahadur Y; El-Sayed ME; Al-Gahmi AM; Rizvi SA; Hassouna AH; Fawzy EE; Awadalla SS
Asia Pac J Clin Oncol; 2010 Jun; 6(2):130-7. PubMed ID: 20565426
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of lymph node ratio in survival of non-metastatic breast carcinoma patients.
Singh D; Mandal A
Breast Cancer Res Treat; 2020 Dec; 184(3):839-848. PubMed ID: 32852709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
